CVC buys 170,071 shares as Recordati stock bid reaches EUR 53.00

Published on 10/21/2026 at 09:47 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

CVC added 170,071 shares on October 20, 2026 at the EUR 53.00 offer price. Recordati stock costs EUR 52.98 on October 21, 2026 before the bid ends.

Takeover timeline and earnings

CVC bought 170,071 Recordati shares at EUR 53.00 on October 20, 2026.
First-half revenue reached EUR 1.4 billion on July 29, 2026.
Recordati stock traded at EUR 52.98 at 9:39 a.m. CEST on October 21, 2026.

Pop-Art-Comic-Illustration eines Wissenschaftlers, der eine große Kapsel hochhält — Recordati S.p.A. (IT0003828271) wird als Pharma-Unternehmen durch diese farbenfrohe Pop-Art-Comic-Illustration mit Wissenschaftler dargestellt, Illustration mit AI erstellt.

Recordati (ISIN IT0003828271) was tied to CVC-backed Respighi BidCo's purchase of 170,071 shares at up to EUR 53.00 on October 20, 2026, according to TipRanks. The transaction keeps the EUR 53.00 offer at the center of the takeover timetable, while Recordati stock was trading at EUR 52.98 at Lang & Schwarz on October 21, 2026 at 9:39 a.m. CEST.

Three takeover dates and figures

On July 29, 2026, Recordati reported first-half revenue of EUR 1.4 billion, up 6.6 percent, while EBITDA reached EUR 540.2 million, up 8.8 percent, according to the Yahoo Finance transcript. On October 14, 2026, Palliser challenged the EUR 53.00 offer and cited 50.49 percent tendered, as Il Sole 24 Ore reported. On October 20, 2026, the bidder bought 170,071 shares and completed an additional 1,372,657-share purchase at EUR 53.00, according to TipRanks.

What does the offer mean for earnings?

The bid is being tested against a business that delivered EUR 1.4 billion of revenue and EUR 540.2 million of EBITDA in the first half of 2026. Rare Disease revenue rose 17.1 percent to EUR 604 million in that period, while the company guided for full-year revenue of EUR 2.73 billion to EUR 2.80 billion, according to the Yahoo Finance transcript. That operating backdrop explains why the offer price remains a central valuation point in the takeover debate.

Two dates remain on the calendar

The voluntary offer is scheduled to end on October 23, 2026, after its extension, according to Il Sole 24 Ore. Recordati's next earnings release is listed for November 10, 2026, with a board meeting on November 9, 2026, according to MarketScreener.

Offer price sets the market frame

The EUR 53.00 offer remains the clearest market reference while the takeover process moves toward its October 23, 2026 deadline. At Lang & Schwarz, Recordati stock was trading intraday at EUR 52.98 on October 21, 2026 at 9:39 a.m. CEST. The further course of trading is shown by the continuously updated real-time quote of Recordati stock.